Dallah Healthcare Company (4004.SR)
SAR 124.2
(-1.11%)
SAR 124.2
(-1.11%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.94 Billion | 2.48 Billion | 2.1 Billion | 1.31 Billion | 1.25 Billion | 1.18 Billion |
| Cost of Revenue | 1.86 Billion | 1.59 Billion | 1.34 Billion | 868.52 Million | 804.24 Million | 744.6 Million |
| Gross Profit | 1.07 Billion | 895.1 Million | 760.36 Million | 449.72 Million | 447.84 Million | 436.33 Million |
| Operating Expenses | 515.16 Million | 465.44 Million | 410.22 Million | 323.81 Million | 293.03 Million | 289.13 Million |
| Selling, General and Administrative Expenses | 548.94 Million | 152.86 Million | 145.74 Million | 80.4 Million | 70.06 Million | 79.69 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -33.78 Million | 312.57 Million | 264.47 Million | 243.4 Million | 222.97 Million | 11.82 Million |
| Cost and Expenses | 2.43 Billion | 2.05 Billion | 1.75 Billion | 1.19 Billion | 1.09 Billion | 1.03 Billion |
| Operating Income | 506.31 Million | 422.44 Million | 364.74 Million | 125.15 Million | 154.39 Million | 146.15 Million |
| Interest Expense | 104.13 Million | 70.49 Million | 41.83 Million | 25.4 Million | 25.09 Million | 11.53 Million |
| Income Tax Expense | 14.89 Million | 33.69 Million | 16.92 Million | 13.43 Million | 4.71 Million | 3.54 Million |
| Earnings before Tax | 400.31 Million | 329.13 Million | 291.83 Million | 113.54 Million | 151.62 Million | 145.29 Million |
| Net Income | 360.12 Million | 274.46 Million | 258.6 Million | 97.12 Million | 146.91 Million | 141.75 Million |
| Earnings Per Share Basic | 3.70 | 3.05 | 2.87 | 1.13 | 1.69 | 1.58 |
| Earnings Per Share Diluted | 3.70 | 3.05 | 2.87 | 1.13 | 1.69 | 1.58 |
| Weighted Average Shares Outstanding | 97.34 Million | 90 Million | 90 Million | 86.07 Million | 87.1 Million | 90 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.34 Million | 90 Million | 90 Million | 86.07 Million | 87.1 Million | 90 Million |
| Gross Margin | 0.37 | 0.36 | 0.36 | 0.34 | 0.36 | 0.37 |
| EBIT Margin | 0.21 | 0.22 | 0.22 | 0.17 | 0.20 | 0.20 |
| Profit Margin | 0.12 | 0.11 | 0.12 | 0.07 | 0.12 | 0.12 |
| EBITDA | 631.92 Million | 536.7 Million | 479.86 Million | 290.18 Million | 273.5 Million | 220.19 Million |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.17 | 0.09 | 0.12 | 0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 765.18 Million | 784.06 Million | 2.94 Billion | 806.01 Million | 749.82 Million | 670.41 Million |
| Cost of Revenue | 468.35 Million | 490.7 Million | 1.86 Billion | 510.07 Million | 468.96 Million | 435.34 Million |
| Gross Profit | 296.82 Million | 293.36 Million | 1.07 Billion | 295.93 Million | 280.86 Million | 235.07 Million |
| Operating Expenses | 161.12 Million | 144.13 Million | 572.36 Million | 161.6 Million | 145.95 Million | 127.68 Million |
| Selling, General and Administrative Expenses | 161.12 Million | 145.88 Million | - | -262.41 Million | 152.17 Million | 142.76 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -156.66 Million | -144.13 Million | -572.36 Million | -161.6 Million | - | - |
| Cost and Expenses | 629.47 Million | 634.83 Million | 2.43 Billion | 671.67 Million | 614.92 Million | 563.03 Million |
| Operating Income | 135.7 Million | 149.23 Million | 506.31 Million | 134.33 Million | 130.96 Million | 102.92 Million |
| Interest Expense | 25.37 Million | 28.95 Million | 104.13 Million | 23.12 Million | 22.63 Million | 29.88 Million |
| Income Tax Expense | 5.32 Million | 3.19 Million | 14.89 Million | -1.85 Million | 4.98 Million | 6.02 Million |
| Earnings before Tax | 115.69 Million | 130.53 Million | 400.31 Million | 114.66 Million | 111.32 Million | 66.82 Million |
| Net Income | 111.84 Million | 119.29 Million | 360.12 Million | 113.65 Million | 98.87 Million | 53 Million |
| Earnings Per Share Basic | 1.15 | 1.22 | - | 1.16 | 1.01 | 0.54 |
| Earnings Per Share Diluted | 1.15 | 1.22 | - | 1.16 | 1.01 | 0.54 |
| Weighted Average Shares Outstanding | 97.65 Million | 97.68 Million | 97.34 Million | 97.68 Million | 97.68 Million | 97.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 97.65 Million | 97.68 Million | 97.34 Million | 97.68 Million | 97.68 Million | 97.68 Million |
| Gross Margin | 0.39 | 0.37 | 0.37 | 0.37 | 0.37 | 0.35 |
| EBIT Margin | 0.22 | 0.25 | - | 0.23 | 0.23 | 0.20 |
| Profit Margin | 0.15 | 0.15 | 0.12 | 0.14 | 0.13 | 0.08 |
| EBITDA | 170.18 Million | 199.45 Million | - | 185.24 Million | 170.54 Million | 130.89 Million |
| Earnings Before Tax Margin | 0.18 | 0.19 | 0.17 | 0.17 | 0.17 | 0.15 |
FOUR
0KAV
NCC-B
4875
6485
FROG